Unbiased Analysis of Today's Healthcare Issues
Let’s look at some data on mean annual physician income in the U.S. compared to other countries: U.S.: $458,100 Canada: $194,700 Netherlands: $185,700 Sweden: $115,200 Why are U.S. physician incomes so much higher than other developed countries? Is it a good idea to try to drive down physician incomes? An NBER working paper by Buehler…
In a recent report, the Association of the British Pharmaceutical Industry (ABPI) examines the UK’s “translational readiness gap”—the persistent failure to move cutting-edge laboratory models into the actual creation of medicines to treat patients. The Attrition Problem and the Translational Gap Modern drug development is a high risk endeavor. Approximately 90% of drug candidates that…
ISPOR Europe kicks off this week in Barcelona, Spain. In honor of ISPOR, I will summarize some key attributes of the Spanish health care system based on a 2024 report from the European Observatory on Health Systems and Policies and the Instituto Aragones de Ciencias de la Salud. Country overview Population: 48.4 million (as of…
This question is particularly relevant with the passage of the Inflation Reduction Act (IRA) and the requirement that CMS negotiate a ‘maximum fair price’ for drugs with the biggest impact on Medicare’s bottom line. A Health Affairs Forefront paper by Lin et al. (2023) compares how drug price negotiation differs between Canada, France, Germany and…
According to the OECD, In 2021 the U.S. spent $1,432/capita on pharmaceuticals compared to only $517/per capita in the UK. The UK’s figure was slightly higher that Poland and Norway, but less than Latvia, the Slovak Republic, Portugal and Romania. How does the UK spend so little on drugs? Many people focus on the efforts…
Out recently is an interesting AEA paper by Okeke 2023, who examines a policy experiment by the Nigerian government that aimed determine whether expand access to physicians improved health outcomes. In this experiment, some communities were randomly selected to receive a new doctor. These doctors were posted to the local public health center. Prior to…
The value of medical devices caries with it less certainty than pharmaceuticals for a variety of reasons. As described in Kovács et al. (2022) medical devices: often have multiple applications, frequently, undergo product modifications and during their product lifecycle, multiple incremental technological innovations take place affecting both clinical and economic consequences of their adoption into…
How well do different countries take care of their elderly and near elderly populations? A study by Macinko et al. (2020) provides some useful statistics. Methods Population of interest. Individuals aged 50 and above sampled across 23 high- and middle-income countries. Data. The data come from 2015 or 2016 years for the following data sets:…
If you are hurt and can’t work to make money, what do you do? In most countries, disabled individuals are eligible for disability insurance. However, the rate of individuals who claim disability insurance varies greatly across countries. Is this largely due to differences in country population characteristics or disability policy generosity? This is the question…
Health technology assessments (HTAs) aim to measure the cost effectiveness of a given treatment or set of treatments for a specific patient populations. Often, these assessments are conducted from the point of view of the payer–either a national health system or the individual insurer perspective. This payer focused perspective can often focus largely on treatment costs rather…